Connection

JAMES C YAO to Animals

This is a "connection" page, showing publications JAMES C YAO has written about Animals.
Connection Strength

0.169
  1. Gastrointestinal neuroendocrine tumors: slow but steady progress. Oncology (Williston Park). 2014 Sep; 28(9):762-3.
    View in: PubMed
    Score: 0.021
  2. PIK3CA/PTEN mutations and Akt activation as markers of sensitivity to allosteric mTOR inhibitors. Clin Cancer Res. 2012 Mar 15; 18(6):1777-89.
    View in: PubMed
    Score: 0.018
  3. Overcoming antiangiogenic resistance. Clin Cancer Res. 2011 Aug 15; 17(16):5217-9.
    View in: PubMed
    Score: 0.017
  4. Potential synergies for combined targeted therapy in the treatment of neuroendocrine cancer. Drugs. 2011 May 07; 71(7):841-52.
    View in: PubMed
    Score: 0.017
  5. Elevated expression of vascular endothelial growth factor correlates with increased angiogenesis and decreased progression-free survival among patients with low-grade neuroendocrine tumors. Cancer. 2007 Apr 15; 109(8):1478-86.
    View in: PubMed
    Score: 0.012
  6. EPA, DHA, and resolvin effects on cancer risk: The underexplored mechanisms. Prostaglandins Other Lipid Mediat. 2024 Oct; 174:106854.
    View in: PubMed
    Score: 0.010
  7. PPARd dysregulation of CCL20/CCR6 axis promotes gastric adenocarcinoma carcinogenesis by remodeling gastric tumor microenvironment. Gastric Cancer. 2023 11; 26(6):904-917.
    View in: PubMed
    Score: 0.010
  8. Rapid acceleration of KRAS-mutant pancreatic carcinogenesis via remodeling of tumor immune microenvironment by PPARd. Nat Commun. 2022 05 13; 13(1):2665.
    View in: PubMed
    Score: 0.009
  9. Identifying the Metabolic Signatures of PPARD-Overexpressing Gastric Tumors. Int J Mol Sci. 2022 Jan 31; 23(3).
    View in: PubMed
    Score: 0.009
  10. Consensus on molecular imaging and theranostics in neuroendocrine neoplasms. Eur J Cancer. 2021 03; 146:56-73.
    View in: PubMed
    Score: 0.008
  11. The FGFR4-G388R single-nucleotide polymorphism alters pancreatic neuroendocrine tumor progression and response to mTOR inhibition therapy. Cancer Res. 2012 Nov 15; 72(22):5683-91.
    View in: PubMed
    Score: 0.005
  12. Combined treatment of pancreatic cancer with mithramycin A and tolfenamic acid promotes Sp1 degradation and synergistic antitumor activity. Cancer Res. 2010 Feb 01; 70(3):1111-9.
    View in: PubMed
    Score: 0.004
  13. Overexpression of phosphorylated mammalian target of rapamycin predicts lymph node metastasis and prognosis of chinese patients with gastric cancer. Clin Cancer Res. 2009 Mar 01; 15(5):1821-9.
    View in: PubMed
    Score: 0.004
  14. Targeted inhibition of Sp1-mediated transcription for antiangiogenic therapy of metastatic human gastric cancer in orthotopic nude mouse models. Int J Oncol. 2008 Jul; 33(1):161-7.
    View in: PubMed
    Score: 0.003
  15. Antitumor activity of rapamycin and octreotide as single agents or in combination in neuroendocrine tumors. Endocr Relat Cancer. 2008 Mar; 15(1):257-66.
    View in: PubMed
    Score: 0.003
  16. Therapeutic inhibition of Sp1 expression in growing tumors by mithramycin a correlates directly with potent antiangiogenic effects on human pancreatic cancer. Cancer. 2007 Dec 15; 110(12):2682-90.
    View in: PubMed
    Score: 0.003
  17. The development and characterization of a human midgut carcinoid cell line. Clin Cancer Res. 2007 Aug 15; 13(16):4704-12.
    View in: PubMed
    Score: 0.003
  18. Molecular basis of the synergistic antiangiogenic activity of bevacizumab and mithramycin A. Cancer Res. 2007 May 15; 67(10):4878-85.
    View in: PubMed
    Score: 0.003
  19. New drug development in digestive neuroendocrine tumors. Ann Oncol. 2007 Aug; 18(8):1307-13.
    View in: PubMed
    Score: 0.003
  20. Association of elevated GRP78 expression with increased lymph node metastasis and poor prognosis in patients with gastric cancer. Clin Exp Metastasis. 2006; 23(7-8):401-10.
    View in: PubMed
    Score: 0.003
  21. Altered expression of transcription factor Sp1 critically impacts the angiogenic phenotype of human gastric cancer. Clin Exp Metastasis. 2005; 22(3):205-13.
    View in: PubMed
    Score: 0.003
  22. A high expression level of insulin-like growth factor I receptor is associated with increased expression of transcription factor Sp1 and regional lymph node metastasis of human gastric cancer. Clin Exp Metastasis. 2004; 21(8):755-64.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.